FDA medical device ID program: Purchasers pleased, industry wary
Group purchasing organization Novation applauds the FDA's proposed unique device identifier program, but med-tech industry lobbying group AdvaMed wants to take a closer look to ensure the program avoid unnecessary burdens.
Medical tech industry stakeholders are showing mixed reactions to the FDA's latest proposal for a system of unique device identifiers that can monitor medical devices for tracking and public health purposes.
Group purchasing organization Novation applauded the FDA's effort, calling it a "significant milestone for patient safety," but representatives at industry lobby AdvaMed are taking a wary approach.
"We are reviewing the details of the proposed UDI rule and, after consultation with our members, will be submitting detailed comments," AdvaMed spokeswoman Wanda Moebius told reporters.